Skip to main content ↑ ↓
Topic: Biogen rises as FDA panel backs Alzheimer’s drug, easing safety concerns (Read 12 times) previous topic - next topic

Biogen rises as FDA panel backs Alzheimer’s drug, easing safety concerns

Biogen rises as FDA panel backs Alzheimer’s drug, easing safety concerns

[html](Reuters) – Shares of Biogen Inc rose 4% in premarket trade on Monday as an unanimous backing of the co*pany’s Alzheimer’s drug…[/html]

Source: Biogen rises as FDA panel backs Alzheimer’s drug, easing safety concerns (http://ht**://www.oann.c**/business/biogen-rises-as-fda/?utm_source=rss&utm_medium=rss&utm_campaign=biogen-rises-as-fda)